Copyright
©The Author(s) 2023.
World J Orthop. Jun 18, 2023; 14(6): 443-457
Published online Jun 18, 2023. doi: 10.5312/wjo.v14.i6.443
Published online Jun 18, 2023. doi: 10.5312/wjo.v14.i6.443
Table 1 Main characteristics of the study population, n (%)
| Knee osteoarthritis (n = 824) | Hip osteoarthritis (n = 278) | All (n = 1102) | |
| Age, (yr), mean (SD) | 60.4 (6.9) | 60.3 (7.2) | 60.4 (7.0) |
| Gender | |||
| Female | 728 (88.3) | 240 (86.3) | 968 (87.8) |
| Male | 96 (11.7) | 38 (13.7) | 134 (12.2) |
| Ethnicity | |||
| Caucasian | 820 (99.5) | 278 (100.0) | 1098 (99.6) |
| Black | 1 (0.1) | 0 | 1 (0.1) |
| Asian | 3 (0.4) | 0 | 3 (0.3) |
| BMI, mean (SD) | 29.77 (5.5) | 28.66 (5.3) | 29.49 (5.5) |
| Scale of stages of osteoarthritis according to Kellgren & Lawrence | |||
| Stage 1 | 81 (9.8) | 35 (12.6) | 116 (10.5) |
| Stage 2 | 617 (74.9) | 211 (75.9) | 828 (75.1) |
| Stage 3 | 125 (15.2) | 32 (11.5) | 157 (14.2) |
| No data available | 1 (0.1) | 1 (0.1) |
- Citation: Lila AM, Alekseeva LI, Baranov AA, Taskina EA, Kashevarova NG, Lapkina NA, Trofimov EA. Chondroitin sulfate and glucosamine combination in patients with knee and hip osteoarthritis: A long-term observational study in Russia. World J Orthop 2023; 14(6): 443-457
- URL: https://www.wjgnet.com/2218-5836/full/v14/i6/443.htm
- DOI: https://dx.doi.org/10.5312/wjo.v14.i6.443